Clinical trial
A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV…
NCT00100048 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00100048 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) |
| Official title | Multicenter, Double-Blind, Randomized, Dose Ranging Study to Compare the Safety and Activity of MK0518 Plus Tenofovir and Lamivudine (3TC) Versus Efavirenz Plus Tenofovir and Lamivudine (3TC) in ART-Naive, HIV-Infected Patients |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Acquired Immunodeficiency Syndrome |
| Intervention type | Drug |
| Interventions | Comparator: MK0518 monotherapy, Comparator: MK0518 combination therapy, Comparator: efavirenz, Comparator: tenofovir, Comparator: lamivudine, Placebo monotherapy |
| Enrollment | 206 |
| Start date | Jan 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jul 1, 2010 |
| First posted | Dec 23, 2004 |
| Last update posted | Sep 9, 2015 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: